-
141
Chronic Tinnitus following Electroconvulsive Therapy
Published 2011-01-01“…A 43-year-old female with a 27-year history of obsessive-compulsive disorder and major depression had previously been treated with psychotherapy, antidepressant, and antipsychotic medications. …”
Get full text
Article -
142
Effect of Lorazepam on the Development of the Hairy Maggot Blow Fly, Chrysomya rufifacies (Macquart): Implication for Forensic Entomology
Published 2023-01-01“…Drugs can accumulate in fly larvae when they ingest the flesh of deceased persons and alter the normal development of the fly causing implications in calculating postmortem intervals. Lorazepam is an antidepressant generally used to treat anxiety. Larvae of Chrysomya rufifacies were fed on the beef liver mixed with lorazepam to study the effect of lorazepam on the developmental rate of larvae and to count delay in postmortem interval. …”
Get full text
Article -
143
New-Onset Panic, Depression with Suicidal Thoughts, and Somatic Symptoms in a Patient with a History of Lyme Disease
Published 2015-01-01“…During inpatient psychiatric hospitalization his psychiatric and physical symptoms did not improve with antidepressant and anxiolytic treatments. The patient’s panic attacks resolved after he was discharged and then, months later, treated with long-term antibiotics for suspected “chronic Lyme Disease” (CLD) despite having negative Lyme titers. …”
Get full text
Article -
144
Hybrid electroconvulsive therapy in an adolescent with major depressive disorder: a case report
Published 2025-01-01“…Here, we report a case study of a 14-year-old male student with major depressive disorder (MDD) suffering from severe suicidality and significant impairment in social functioning who achieved effective antidepressant effects with HECT and improved cognitive function. …”
Get full text
Article -
145
A Revision on the Effectiveness of Omega-3 Polyunsaturated Fatty Acids as Monotherapy in the Treatment of Major Depressive Disorder
Published 2022-01-01“…Insufficient effectiveness and a difficult tolerability profile of antidepressant drugs for the treatment of major depressive disorder (MDD) have been reported, and polyunsaturated fatty acids (PUFAs) have been posited as reliable therapeutic alternatives. …”
Get full text
Article -
146
Therapeutic Potential of 5-HT2C Receptor Ligands
Published 2010-01-01“…More precisely, blockade of serotonin 2C receptors has been suggested to provide antidepressant and anxiolytic benefit, while stimulation of these receptors may offer therapeutic benefit for the treatment of psychotic symptoms in schizophrenia and obesity. …”
Get full text
Article -
147
Prediction of individual patient outcomes to psychotherapy vs medication for major depression
Published 2025-02-01“…Abstract Treatments for major depressive disorder (MDD) include antidepressant medications and evidence-based psychotherapies, which are approximately equally efficacious. …”
Get full text
Article -
148
An Insight into Potential Pharmacotherapeutic Agents for Painful Diabetic Neuropathy
Published 2022-01-01“…Clinical studies have shown that anticonvulsant and antidepressant therapies have proven fruitful in management of pain associated with PDN. …”
Get full text
Article -
149
Navigating the depths: A comprehensive narrative review on depression in people with epilepsy
Published 2025-01-01“…Our review highlights that the use of most antidepressant pharmacotherapies does not increase the risk of seizure occurrences. …”
Get full text
Article -
150
Maternal Characteristics of Women Exposed to Hypnotic Benzodiazepine Receptor Agonist during Pregnancy
Published 2014-01-01“…Compared to unexposed women, exposed women were characterized by being older, with higher BMI, in their third or fourth parity, of lower income and education level, more frequently smokers, and more likely to be comedicated with antipsychotic, anxiolytic, or antidepressant drugs (P<0.0001). Conclusion. Women using HBRAs during their pregnancy differ from unexposed women in socioeconomic factors and were more likely to receive comedication. …”
Get full text
Article -
151
Adult-Onset Idiopathic Cervical Dystonia
Published 2022-12-01“…Comprehensive modern management of patients with AOICD requires recognition of presence of mood disorders, and actively treating the endogenous mood disorder with antidepressant therapy. Botulinum toxin injections alone, no matter how expertly given, will not provide optimal therapy and improved health-related quality of life without an holistic approach to patient management. …”
Get full text
Article -
152
Kleptomania Induced by Venlafaxine
Published 2021-01-01“…This is the fourth report of venlafaxine-induced kleptomania and highlights the importance of considering the possibility of a rare side effect of kleptomania induced by antidepressant.…”
Get full text
Article -
153
Cannabidiol Modulates Neuroinflammatory and Estrogen-Related Pathways in a Sex-Specific Manner in a Chronic Stress Model of Depression
Published 2025-01-01“…These findings highlight the sex-specific mechanisms of CBD’s antidepressant effect, with hippocampal neuroinflammatory and estrogenic pathways playing a key role in males.…”
Get full text
Article -
154
The Role of Neurokinin-1 Receptor in the Microenvironment of Inflammation and Cancer
Published 2012-01-01“…Antagonists against the NK-1 receptor are safe clinical drugs that are known to have anti-inflammatory, analgesic, anxiolytic, antidepressant, and antiemetic effects. Recently, it has become apparent that SP can induce tumor cell proliferation, angiogenesis, and migration via the NK-1 receptor, and that the SP/NK-1 receptor complex is an integral part of the microenvironment of inflammation and cancer. …”
Get full text
Article -
155
Agomelatine Efficacy in the Night Eating Syndrome
Published 2013-01-01“…This paper describes a case report of an NES patient treated with agomelatine, an antidepressant analogue of melatonin, which acts by improving not only the mood but also by regulating sleep cycles and appetite. …”
Get full text
Article -
156
Depression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines
Published 2019-01-01“…Currently available antidepressant drugs are notoriously problematic, with suboptimal remission rates and troubling side-effect profiles. …”
Get full text
Article -
157
Possible Protective Effect of Sertraline against Cisplatin-Induced Ototoxicity: An Experimental Study
Published 2013-01-01“…The aim of this study was to evaluate the otoprotective effect of sertraline, which is an antidepressant with neuroprotective effects, against cisplatin, in rats. …”
Get full text
Article -
158
Comparison of Different Machine Learning Methodologies for Predicting the Non‐Specific Treatment Response in Placebo Controlled Major Depressive Disorder Clinical Trials
Published 2025-01-01“…ABSTRACT Placebo effect represents a serious confounder for the assessment of treatment effect to the extent that it has become increasingly difficult to develop antidepressant medications appropriate for outperforming placebo. …”
Get full text
Article -
159
Phenotyping the males of mouse and rat strains with genetically defined behavioral disturbances in a model of sexual activation
Published 2015-12-01“…The main gene for a high predisposition to catalepsy was shown to be associated with the expression of sexual motivation, but not with the hormonal component of sexual arousal (increase in plasma testosterone levels following exposure to a receptive female). ASC (Antidepressant Sensitive Catalepsy) mice, proposed as a model of depression, had a decreased manifestation of sexual motivation, while male GC (Genetic Catalepsy) strain rats had enhanced sexual motivation. …”
Get full text
Article -
160
Magnetic Seizure Therapy for Unipolar and Bipolar Depression: A Systematic Review
Published 2015-01-01“…The studies found reported significant antidepressant effects, with remission rates ranging from 30% to 40%. …”
Get full text
Article